BR112021018687A2 - Combinação de dose fixa de canabinoides e cogumelos medicinais para prevenção e tratamento de câncer, doenças inflamatórias ou inflamatórias imunomediadas - Google Patents

Combinação de dose fixa de canabinoides e cogumelos medicinais para prevenção e tratamento de câncer, doenças inflamatórias ou inflamatórias imunomediadas

Info

Publication number
BR112021018687A2
BR112021018687A2 BR112021018687A BR112021018687A BR112021018687A2 BR 112021018687 A2 BR112021018687 A2 BR 112021018687A2 BR 112021018687 A BR112021018687 A BR 112021018687A BR 112021018687 A BR112021018687 A BR 112021018687A BR 112021018687 A2 BR112021018687 A2 BR 112021018687A2
Authority
BR
Brazil
Prior art keywords
cancer
immune
cannabinoids
prevention
treatment
Prior art date
Application number
BR112021018687A
Other languages
English (en)
Inventor
Itschak Lamensdorf
Yona Levy
Original Assignee
Alvit Lcs Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alvit Lcs Pharma Ltd filed Critical Alvit Lcs Pharma Ltd
Publication of BR112021018687A2 publication Critical patent/BR112021018687A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

combinação de dose fixa de canabinoides e cogumelos medicinais para prevenção e tratamento de câncer, doenças inflamatórias ou inflamatórias imunomediadas. a invenção refere-se a uma composição útil para tratamento de doenças inflamatórias imunomediadas ou câncer em mamíferos. a composição compreende uma combinação sinérgica de um composto derivado de cannabis e um cogumelo medicinal.
BR112021018687A 2019-03-21 2020-03-20 Combinação de dose fixa de canabinoides e cogumelos medicinais para prevenção e tratamento de câncer, doenças inflamatórias ou inflamatórias imunomediadas BR112021018687A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962821461P 2019-03-21 2019-03-21
PCT/IL2020/050337 WO2020188577A1 (en) 2019-03-21 2020-03-20 Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseases

Publications (1)

Publication Number Publication Date
BR112021018687A2 true BR112021018687A2 (pt) 2021-12-14

Family

ID=72519803

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021018687A BR112021018687A2 (pt) 2019-03-21 2020-03-20 Combinação de dose fixa de canabinoides e cogumelos medicinais para prevenção e tratamento de câncer, doenças inflamatórias ou inflamatórias imunomediadas

Country Status (9)

Country Link
US (1) US20220160801A1 (pt)
EP (1) EP3941458A4 (pt)
JP (2) JP7511915B2 (pt)
CN (1) CN113966218A (pt)
AU (1) AU2020244352A1 (pt)
BR (1) BR112021018687A2 (pt)
CA (1) CA3134241C (pt)
IL (1) IL286549B2 (pt)
WO (1) WO2020188577A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022091050A1 (en) * 2020-10-31 2022-05-05 Ai Pharmaceuticals Jamaica Limited Compositions for treatment of interstitial cystitis and other bladder disease
WO2022091051A1 (en) * 2020-10-31 2022-05-05 Ai Pharmaceuticals Jamaica Limited Cannabis compositions and emulsions
WO2022187973A1 (en) * 2021-03-12 2022-09-15 Allied Corp. Dosing regimens of pharmaceutical and nutraceutical mushroom and cannabis compositions and their use to treat cns disorders and improve mental health
EP4308137A1 (en) * 2021-03-16 2024-01-24 Cannabotech Ltd. Novel mushroom strains, extracts thereof and compositions comprising them
IT202100029000A1 (it) 2021-11-16 2023-05-16 C I A M S R L Composizioni immunostimolanti per animali da compagnia
CN114831998B (zh) * 2022-04-28 2023-09-22 山西省人民医院 栓菌酸在肾病治疗中的应用
CN116421634B (zh) * 2023-06-12 2023-09-12 江西金水宝制药有限公司 一种Cs-4虫草菌粉提取物及其制备方法和应用
CN117414369A (zh) * 2023-12-19 2024-01-19 中国中医科学院中药研究所 灵芝酸t在制备类风湿性关节炎药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7597910B2 (en) * 2005-08-20 2009-10-06 Slgm Medical Research Institute Compositions and methods for treating prostate disorders
CN102579510A (zh) * 2011-01-10 2012-07-18 刘振权 冬虫夏草的一种新用途
US8642645B2 (en) * 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids
KR20150106015A (ko) * 2014-03-10 2015-09-21 건국대학교 산학협력단 전복 발효물 또는 이의 추출물을 함유하는 항염 조성물 및 전복 발효물의 제조방법
MX2017007550A (es) * 2014-12-12 2018-05-04 Ojai Energetics Pbc Composiciones microencapsuladas de cannabinoides.
US10238745B2 (en) * 2015-01-31 2019-03-26 Constance Therapeutics, Inc. Cannabinoid composition and products including α-tocopherol
CA2974292C (en) * 2015-01-31 2024-04-16 Constance Therapeutics, Inc. Methods for preparation of cannabis oil extracts and compositions
EP3319446A4 (en) * 2015-07-06 2019-07-03 Cg- Bio Genomics, Inc. HEALTHY COMPLEMENTS
EA201990032A1 (ru) * 2016-06-15 2019-06-28 ОХАЙ ЭНЕРДЖЕТИКС ПиБиСи Способы и композиции для терапии посредством потенциирования стволовых клеток
US20180221333A1 (en) * 2017-03-22 2018-08-09 Rise Research Inc Optimized cannabis-based aphrodisiac and mood enhancer

Also Published As

Publication number Publication date
CN113966218A (zh) 2022-01-21
IL286549B2 (en) 2023-02-01
WO2020188577A1 (en) 2020-09-24
IL286549B (en) 2022-10-01
IL286549A (en) 2021-12-01
JP2024081791A (ja) 2024-06-18
EP3941458A1 (en) 2022-01-26
JP7511915B2 (ja) 2024-07-08
CA3134241C (en) 2022-10-25
AU2020244352A1 (en) 2021-11-11
JP2022530188A (ja) 2022-06-28
EP3941458A4 (en) 2022-05-25
US20220160801A1 (en) 2022-05-26
CA3134241A1 (en) 2020-09-24

Similar Documents

Publication Publication Date Title
BR112021018687A2 (pt) Combinação de dose fixa de canabinoides e cogumelos medicinais para prevenção e tratamento de câncer, doenças inflamatórias ou inflamatórias imunomediadas
BR112020017090A8 (pt) Imunoterapias relacionadas com microbioma
MX2021009246A (es) Inmunomoduladores, composiciones y metodos de los mismos.
CL2020002018A1 (es) Composiciones para modular la expresión de c9orf72. (divisional solicitud 201803582)
CL2019000268A1 (es) Composición de cannabis.
BR112017026739A2 (pt) compostos para uso no tratamento de distúrbios neuromusculares
CL2018001897A1 (es) Composiciones para modular la expresión de sod-1 (divisional solicitud 201602509)
PE20180243A1 (es) Composiciones que comprenden cepas bacterianas
WO2018022668A3 (en) NEUROMODULATORY COMPOSITIONS AND ASSOCIATED METHODS OF TREATING CANCER
BR112022007677A2 (pt) L-asparaginase recombinante
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
BR112016020199A8 (pt) composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
MX2020011542A (es) Inhibidores de cd73.
BR112018008601A2 (pt) composições compreendendo o canabidiol e segundos agentes terapêuticos para o tratamento de câncer
AR101740A1 (es) Terapia de combinación y composiciones
BR112022010082A2 (pt) Composto de fórmula estrutural i ou sal do mesmo, composição farmacêutica, uso do composto e uso da composição farmacêutica
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
NZ788133A (en) Cd73 inhibitors
CY1124907T1 (el) Αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
MX2021015770A (es) Inhibidores macrociclicos de mcl-1.
MX2022000390A (es) Derivados macrociclicos espirociclicos como inhibidores de mcl-1.
BR112022005627A2 (pt) Composto de fórmula estrutural i ou um sal do mesmo, composição farmacêutica e uso de um composto
BR112022009710A2 (pt) Terapia de combinação compreendendo um inibidor de alk2 e um inibidor de jak2
MX2020011826A (es) Composiciones de combinacion que comprenden compuestos de bisfluoroalquil-1,4-benzodiazepinona y metodos de uso de las mismas.